Global Companion Diagnostics Market to reach a market size of $6.5 billion by 2025- KBV Research

Global Companion Diagnostics Market to reach a market size of $6.5 billion by 2025- KBV Research
According to a new report Global Companion Diagnostics Market, published by KBV Research, The Global Companion Diagnostics Market size is expected to reach $6.5 billion by 2025, rising at a market growth of 19.9% CAGR during the forecast period.


The Polymerase Chain Reaction (PCR) market dominated the Global Companion Diagnostics Market by Technology in 2018, growing at a CAGR of 20.3% during the forecast period. The Immunohistochemistry market is expected to witness a CAGR of 19.1% during (2019-2025).


The Oncology market dominated the Global Companion Diagnostics Market by Indication in 2018, growing at a CAGR of 21.1 % during the forecast period. The Neurology market is expected to witness a CAGR of 18.3% during (2019-2025).


The North America market dominated the Global Lung Cancer Companion Diagnostics by Region in 2018, growing at a CAGR of 21.7 % during the forecast period. The Europe market is expected to witness a CAGR of 19.9% during (2019-2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 23.5% during (2019-2025).


Full Report: https://www.kbvresearch.com/companion-diagnostics-market/


The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Agilent Technologies, Inc., Almac Group, ARUP Laboratories, Inc., Abbott Laboratories (Abbott Laboratories Molecular, Inc.), Danaher Corporation, Thermo Fisher Scientific, Inc., Hologic, Inc., Novartis AG, Illumina, Inc., Qiagen N.V.


Global Companion Diagnostics Market Segmentation


By Technology


Immunohistochemistry


Polymerase chain reaction (PCR)


Next generation sequencing (NGS)


In Situ Hybridization and


Other Technology


By Indication


Oncology


Neurology and


Other Indications


By Cancer Type


Breast Cancer


Colorectal Cancer


Lung Cancer


Blood Cancer and


Other Cancer Type


By Geography


North America


US


Canada


Mexico


Rest of North America


Europe


Germany


UK


France


Russia


Spain


Italy


Rest of Europe


Asia Pacific


China


Japan


India


South Korea


Singapore


Australia


Rest of Asia Pacific


LAMEA


Brazil


Argentina


UAE


Saudi Arabia


South Africa


Nigeria


Rest of LAMEA


Companies Profiled


Agilent Technologies, Inc.


Almac Group


ARUP Laboratories, Inc.


Abbott Laboratories (Abbott Laboratories Molecular, Inc.)


Danaher Corporation


Thermo Fisher Scientific, Inc.


Hologic, Inc.


Novartis AG


Illumina, Inc.


Qiagen N.V.


Companion Diagnostics Market Related Reports:


North America Market


Europe Market


Asia Pacific Market


LAMEA Market


 

FECHA: a las 07:30h (37 Lecturas)

TAGS: Companion Diagnostics, KBV Research, Companion Diagnostics Market, Companion Diagnostics Market Size

EN: Bienestar